- Home
- TTNP vs SOBR Comparison
TTNP vs SOBR Comparison
Compare TTNP & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- SOBR
- Stock Information
- Founded
- TTNP 1991
- SOBR 2004
- Country
- TTNP United States
- SOBR United States
- Employees
- TTNP N/A
- SOBR N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- SOBR Newspapers/Magazines
- Sector
- TTNP Health Care
- SOBR Consumer Discretionary
- Exchange
- TTNP Nasdaq
- SOBR Nasdaq
- Market Cap
- TTNP 5.4M
- SOBR 5.4M
- IPO Year
- TTNP 1996
- SOBR N/A
- Fundamental
- Price
- TTNP $4.93
- SOBR $3.40
- Analyst Decision
- TTNP
- SOBR
- Analyst Count
- TTNP 0
- SOBR 0
- Target Price
- TTNP N/A
- SOBR N/A
- AVG Volume (30 Days)
- TTNP 49.3K
- SOBR 43.1K
- Earning Date
- TTNP 08-26-2025
- SOBR 08-07-2025
- Dividend Yield
- TTNP N/A
- SOBR N/A
- EPS Growth
- TTNP N/A
- SOBR N/A
- EPS
- TTNP N/A
- SOBR N/A
- Revenue
- TTNP N/A
- SOBR $301,400.00
- Revenue This Year
- TTNP N/A
- SOBR N/A
- Revenue Next Year
- TTNP N/A
- SOBR N/A
- P/E Ratio
- TTNP N/A
- SOBR N/A
- Revenue Growth
- TTNP N/A
- SOBR 73.21
- 52 Week Low
- TTNP $3.03
- SOBR $2.41
- 52 Week High
- TTNP $14.80
- SOBR $193.50
- Technical
- Relative Strength Index (RSI)
- TTNP 62.92
- SOBR 43.68
- Support Level
- TTNP $4.64
- SOBR $3.04
- Resistance Level
- TTNP $5.17
- SOBR $3.75
- Average True Range (ATR)
- TTNP 0.29
- SOBR 0.25
- MACD
- TTNP 0.11
- SOBR -0.06
- Stochastic Oscillator
- TTNP 83.67
- SOBR 26.67
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.